The relationship of age, sex and prothrombin time related to the severity and mortality of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis
Open Access
- 5 June 2024
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 729
Abstract
Background SARS-CoV-2 first appeared in Wuhan, China, in December 2019. Looking at the prevalence data in the world and in Indonesia, the highest mortality rate due to COVID-19 involves age, gender and comorbidities such as diabetes mellitus. Severity of the condition also refers to coagulation abnormalities, such as abnormal prothrombin time values. Methods This systematic review study and meta-analysis used online literature sourced from PubMed, Science Direct, EBSCO, Cochrane and Google Scholar. The literature used here is literature that has data on age, sex and prothrombin time of COVID-19 patients with diabetes mellitus whose quality is assessed by the NOS (Newcastle-Ottawa Scale) criteria and processing data using Review Manager 5.4. Results Out of 8711 literatures that were traced from various search sources, there were 46 literatures that were included in this study. The results of the analysis on age showed the Standardized Mean Difference (SMD) value of 0.45 and P <0.0001 (95% CI: 0.23–0.68), the gender analysis showed an Odds Ratio (OR) value of 3.28 and P = 0.01 (95% CI: 1.26–8.52) and the prothrombin time analysis showed SMD values of 0.41 and P = 0.07 (95%CI = -0.03–0.85). Conclusion Older and male COVID-19 patients have a higher risk of having diabetes compared to younger and female COVID-19 patients. As diabetes is a comorbidity in COVID-19, it can be concluded that old age and male sex are associated with a more severe disease.Keywords
This publication has 51 references indexed in Scilit:
- Diabetes predicts severity of COVID‐19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C‐reactive proteinJournal of Medical Virology, 2021
- Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19Journal of Diabetes & Metabolic Disorders, 2021
- The Relationship Between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, ChinaThe American Journal of Medicine, 2021
- The association of diabetes and the prognosis of COVID-19 patients: A retrospective studyDiabetes Research and Clinical Practice, 2020
- Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and DiabetesInfectious Diseases and Therapy, 2020
- Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitusDiabetes Research and Clinical Practice, 2020
- Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitusDiabetes Research and Clinical Practice, 2020
- Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment centerDiabetes Research and Clinical Practice, 2020
- A novel indicator predicts 2019 novel coronavirus infection in subjects with diabetesDiabetes Research and Clinical Practice, 2020
- Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre studyDiabetes Research and Clinical Practice, 2020